Skip to Content
Merck
All Photos(4)

Key Documents

View All Documentation

T5141

Sigma-Aldrich

Glyceryl trimyristate

≥99%

Synonym(s):

TG(14:0/14:0/14:0), 1,2,3-Tritetradecanoylglycerol, Glycerol trimyristate, Trimyristin

Sign Into View Organizational & Contract Pricing
All Photos(4)

About This Item

Linear Formula:
[CH3(CH2)12COOCH2]2CHOCO(CH2)12CH3
CAS Number:
555-45-3
Molecular Weight:
723.16
Beilstein:
1718242
EC Number:
209-099-7
MDL number:
MFCD00036229
UNSPSC Code:
12352211
PubChem Substance ID:
24900261
NACRES:
NA.25

biological source

plant (palm)

Assay

≥99%

form

powder

mp

56-57 °C (lit.)

functional group

ester

lipid type

neutral glycerides

shipped in

ambient

SMILES string

CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC

InChI

1S/C45H86O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-43(46)49-40-42(51-45(48)39-36-33-30-27-24-21-18-15-12-9-6-3)41-50-44(47)38-35-32-29-26-23-20-17-14-11-8-5-2/h42H,4-41H2,1-3H3

InChI key

DUXYWXYOBMKGIN-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000375482
0000372961
0000338562
0000338564
0000375482

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Kesavan Bhaskar et al.
Drug development and industrial pharmacy, 35(1), 98-113 (2008-07-31)
The purpose of this research was to investigate novel particulate carrier systems such as solid lipid nanoparticles (SLN) and nanostructured lipid carrier (NLC) for transdermal delivery of nitrendipine (NDP). For this investigation, four different gel-forming agents were selected for hydrogel
Carsten Olbrich et al.
International journal of pharmaceutics, 237(1-2), 119-128 (2002-04-17)
In vivo drug release from solid lipid nanoparticles (SLN) takes place by diffusion and degradation of the lipid matrix. SLN with different degree of crystallinity were prepared to study the effect of crystallinity on the degradation velocity. These SLN were
Aditya P Nayak et al.
Colloids and surfaces. B, Biointerfaces, 81(1), 263-273 (2010-08-07)
In the present work, curcuminoids-loaded lipid nanoparticles for parenteral administration were successfully prepared by a nanoemulsion technique employing high-speed homogenizer and ultrasonic probe. For the production of nanoparticles, trimyristin, tristerin and glyceryl monostearate were selected as solid lipids and medium
W Vogelhuber et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 55(1), 133-138 (2003-01-29)
Monolithic lipid matrices were developed that allow parenteral drug release for days, weeks or even months. The cylindrical matrices consist of triglycerides or triglyceride/cholesterol mixtures and allow, due to their small dimensions, an application via injection. Pure triglyceride matrices showed
Andreas W Sonesson et al.
Langmuir : the ACS journal of surfaces and colloids, 23(5), 2706-2713 (2007-01-31)
We have studied the mobility of active and inactive Thermomyces lanuginosus lipase (TLL) on a spin-coated trimyristin substrate surface using fluorescence recovery after photobleaching (FRAP) in a confocal microscopy setup. By photobleaching a circular spot of fluorescently labeled TLL adsorbed
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service